An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
Active, not recruiting · NCT04740476 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Active, not recruiting | Phase 2 | 2026-02-04 | NCT04740476 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stoke Therapeutics, Inc | 2 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.